← FDA Drug Approvals (Drugs@FDA)

DOCETAXEL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SHILPA · Approved 2019-05-16

Drug application

FDA Application #

ANDA210327

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOCETAXEL

Generic name

DOCETAXEL

Active ingredients

DOCETAXEL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SHILPA

Manufacturer

Armas Pharmaceuticals Inc.

First approval

2019-05-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown